The involvement of purinergic receptors in ALS has been documented, such as the P2X4 receptor subtype, which is implicated in neuroprotection (Andries et al., 2007) and microglial activation (Tsuda et al., 2003). The gene discussed is P2RX4; the disease is amyotrophic lateral sclerosis.